inTEST's Q1 dip is short-term noise, since the real revenue should arrive in the second half of 2026 as orders tied to silicon photonics and HBM testing flood in. Revenue rose 27.2% to $33.9 million, margins expanded 400bp to 45.5%, backlog grew 35.5% to $51.8 million, and 2026 guidance rose to $130-135 million. The stock fell because new orders dropped 15.2% sequentially to $31.8 million, but hitting guidance implies heavy H2 orders, with volume testing lagging 1.6T sampling by 3-6 months. x.com x.com x.com x.comÂ

